Quotables
"Fooling around with alternating current is just a waste of time. Nobody will use it, ever."
Thomas Edison ; 1889
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7166601 | Substituted diamine derivatives useful as motilin antagonists The present invention relates to novel substituted diamine derivatives for the formula wherein R1, R2, R3, R4, X1, X2, X | 01/23/2007 |
| 6908908 | Biologically active 4H-benzo [1,4] oxazin-3-ones The invention is directed to 4h-benzo[1,4]oxazin-3-ones useful as peroxisome proliferator activated receptor gamma (PPARγ) agonists or antagonists. Pharmaceutical compositions comprising compounds of the present invention and methods of treating conditions such as ... | 06/21/2005 |
| 6743792 | 6-azauracil derivatives as IL-5 inhibitors The present invention is concerned with the use of compounds of formula the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein p represents 0, 1, 2 or 3; q r... | 06/01/2004 |
| 6562867 | Carbamate compounds for use in preventing or treating bipolar disorder This invention is directed to a method for preventing or treating bipolar disorder comprising administering to a subject in need thereof a therapeutically effective amount of a compound of Formula (I): ##STR1## wherein phenyl is substituted at X with one ... | 05/13/2003 |
| 6476018 | Fused imidazole derivatives as multidrug resistance modulators This invention concerns the compounds of formula ##STR1## the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein the dotted line is an optional bond; n is 1 or 2; R1 is hydroge... | 11/05/2002 |
| 6451802 | S-oxide lipid lowering compounds The present invention relates to compounds of formula (I) ##STR1## the N-oxides, the stereochemically isomeric forms thereof, and the pharmaceutically acceptable acid addition salts, wherein n is 1 or 2, R1 is hydrogen, C1-6 alkyl or... | 09/17/2002 |
| 6452013 | Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives The present invention of compounds of formula (I) ##STR1## a stereochemically isomeric form thereof, an N-oxide form thereof or a pharmaceutically acceptable acid addition salt thereof, R1 is C1-6 alkyloxy, C2-6 alkenyloxy... | 09/17/2002 |
| 6440440 | Biocidal benzylbiphenyl derivatives This invention concerns compounds of formula. ##STR1## stereochemically isomeric forms thereof, acid or base addition salts thereof, N-oxides thereof, or quaternary ammonium derivatives thereof, wherein the dotted line is an optional bond; X is a direct b... | 08/27/2002 |
| 6413988 | Prucalopride oral solution The present invention is concerned with the an oral aqueous solution comprising prucalopride or pharmaceutically acceptable acid addition salts thereof having good organoleptic properties.... | 07/02/2002 |
| 6403589 | Method of treating pain with draflazine-analogues This invention concerns the use of nucleoside transport inhibitors, more particularly compounds of formula ##STR1## an N-oxide form, a pharmaceutically acceptable acid addition salt or a stereochemically isomeric form thereof, wherein R1 is C | 06/11/2002 |
| 6384031 | Cyclobutene derivatives useful as antagonists of the motilin receptor The compounds of formula I are useful in treating gastrointestinal disorders associated with antagonizing the motilin receptor. The compounds compete with erythromycin and motilin for the motilin receptor. In addition the compounds are antagonists of the ... | 05/07/2002 |
| 6384233 | Process for preparing 1,5-diaryl-3-substituted pyrazoles A process for making a compound of formula I wherein the substituents are as described in the specification comprising reacting a ketone of formula II with succinic anhydride and an alkoxide base to form a compound of formula III ##STR1## which is re... | 05/07/2002 |
| 6372246 | Polyethylene glycol coating for electrostatic dry deposition of pharmaceuticals The invention relates to a substrate coating for the electrostatic deposition of dry powder medicaments for use in the manufacture of pharmaceutical dosage forms comprising micronized polyethylene glycol (PEG), with A molecular weight in the range of 1,00... | 04/16/2002 |
| 6310077 | Enterokinetic benzamide The present invention is concerned with a novel benzamide of formula (I). ##STR1## Pharmaceutical compositions comprising said novel compounds, process for preparing compounds and compositions, and the use thereof as a medicine, in particular in the treat... | 10/30/2001 |
| 6291481 | N-substituted 4-(4'-aminobenzoyl)-oxymethyl)-piperidines having gastric prokinetic properties Compounds of formula I ##STR1## the N-oxide forms, the pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, wherein the substituents are as described in the specification, and process for preparing said pro... | 09/18/2001 |
| 6274599 | Cisapride extended release The present invention concerns extended release formulations comprising cisapride-(L)-tartrate, in particular an oral formulation, the use thereof as a medicine, especially in treating gastrokinetic disorders.... | 08/14/2001 |
| 6258956 | Synthesis of 3-amino-3-aryl propanoates A process for the synthesis of a compound of the formula ##STR1## wherein R1 is aryl, heteroaryl, substituted aryl or substituted heteroaryl and R2 is hydrogen, alkyl or aralkyl, or salt thereof.... | 07/10/2001 |
| 6235745 | Use of 5HT3, antagonists for promoting intestinal lavage The present invention is concerned with the use of 5HT3 antagonists for promoting intestinal lavage, especially in combination with an osmotic agent.... | 05/22/2001 |
| 6224905 | Biconvex rapidly disintegrating dosage forms A method for preparing solid rapidly disintegrating dosage forms shaped as biconvex tablets having symmetrical top and bottom surfaces and dosage forms obtainable thereby.... | 05/01/2001 |
| 6201119 | Antiretroviral tetrahydroimidazo[1,4]benzodiazepin-2(thi) ones The compounds are of the class 1,4-benzodiazepines of the formula: ##STR1## An illustrative compound is (S)-6-chloro-2,3,4,5-tetrahydro-3-methyl-4-(3-methyl-2-butenyl)-1H-1,4-ben zodiazepin-9-amine. The compounds are useful as intermediates in the pre... | 03/13/2001 |
| 6153623 | Cisapride extended release The present invention concerns extended release formulations comprising cisapride-(L)-tartrate, in particular an oral formulation, the use thereof as a medicine, especially in treating gastrokinetic disorders.... | 11/28/2000 |
| 6133277 | (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties The present invention of compounds of formula (I) a stereochemically isomeric form thereof, an N-oxide form thereof or a pharmaceutically acceptable acid addition salt thereof, wherein Alk1 is C1-6 alkanediyl optionally substituted w... | 10/17/2000 |
| 6126970 | Cisapride sustained release The present invention concerns pharmaceutical dosage forms comprising cisapride-(L)-tartrate or a precursor form thereof, contained in a porous structure consisting essentially of one or more polymers which are insoluble or practically insoluble in water ... | 10/03/2000 |
| 6113937 | Sustained release sufentanil compositions The present invention concerns sustained release sufentanil compositions for intramuscular administration, the preparation of said compositions and the use of said compositions for inhibiting pain, in particular post-operative pain, in animals, particular... | 09/05/2000 |
| 6100262 | (2-morpholinylmethyl) benzamide derivatives The present invention concerns novel (2-morpholinylmethyl)benzamide derivatives having the formula ##STR1## the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein R1 is C | 08/08/2000 |
| 6096761 | Esters of 3-hydroxy-piperidinemethanol derivatives The present invention of compounds of formula (I), ##STR1## a stereochemically isomeric form thereof, an N-oxide form thereof or a pharmaceutically acceptable acid addition salt thereof, R1 is C1-6 alkyloxy, C2-6 alke... | 08/01/2000 |
| 6054462 | Intranasal antimigraine compositions The present invention relates to a composition comprising an antimigraine compound of formula (I) and chitosan, which is particularly suited for intranasal administration. ##STR1## Process for preparing said composition, its use as a medicine and a n... | 04/25/2000 |
| 6030988 | Immediate release pH-independent solid dosage form of cisapride The present invention concerns oral dosage forms of some particular salts of cisapride, more particularly cisapride-(L)-tartrate, cisapride-(D)-tartrate, cisapride-sulfate, or cisapride citrate, which avoid drugfood interaction and which allow comedicatio... | 02/29/2000 |
| 5990159 | Use of 5HT4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors The present invention concerns the use of receptor antagonists of the 5HT4 receptor for avoiding, alleviating, suppressing or overcoming the gastrointestinal side-effects of serotonin reuptake inhibitors. The present invention also concerns pharmaceutical... | 11/23/1999 |
| 5985878 | Angiogenesis inhibiting pyridazinamines This invention concerns compounds of formula the N-oxide forms, the pharmaceutically acceptable acid addition salts and stereochemically isomeric forms thereof, wherein X is CH or N; m is 2 or 3 and n is 1, 2 or 3; wherein 1 or 2 C-atoms of the CH2 | 11/16/1999 |
| 5977349 | Chromatographic purification of chlorinated sucrose A process for separating, in the liquid phase, a reaction mixture which comprises a first chlorinated sucrose and at least one additional component selected from the group consisting of at least one other chlorinated sucrose different from said first chlo... | 11/02/1999 |
| 5968365 | Preparation of inulin products A process is described for clarifying a crude inulin extract by ultrafiltration and separating an aqueous inulin solution containing carbohydrates having a range of degrees of polymerization into fractions having different average degrees of polymerizatio... | 10/19/1999 |
| 5955485 | Use of fused benzothiazoles as neuroprotectants The present invention is concerned with the method of using a 2,3-dihydro-imidazo2,1-b!benzothiazole derivative for the manufacture of a medicament for the therapeutic or prophylactic treatment of humans suffering from ageing of, or degenerative disease... | 09/21/1999 |
| 5948794 | Enterokinetic benzamide The present invention is concerned with a novel benzamide derivative for formula (I). ##STR1## Pharmaceutical compositions comprising said novel compounds, processes for preparing compounds and compositions, and the use thereof as a medicine, in... | 09/07/1999 |
| 5932569 | Triazolobenzazepine derivatives Antiallergic triazolobenzazepines of formula ##STR1## wherein each of the dotted lines independently represents an optional bond; R1 represents hydrogen, halo, C1-4 alkyl, hydroxy or C1-4 alkyloxy; R2 repre... | 08/03/1999 |
| 5929075 | Apolipoprotein-B synthesis inhibitors The present invention provides novel compounds of formula ##STR1## the N-oxides, the stereochemically isomeric forms thereof, and the pharmaceutically acceptable acid addition salts thereof, wherein A and B taken together form a bivalent radical of f... | 07/27/1999 |
| 5922113 | Antibacterial and antifouling oxathiazines and their oxides Use of 3-aryl-5,6-dihydro-1,4,2-oxathiazines and their oxides having the formula ##STR1## wherein n is 0, 1 or 2; R1 is hydrogen, C1-4 alkyl or benzyl; and R represents (a) phenyl; phenyl substituted with 1 to 3 substituents ... | 07/13/1999 |
| 5922718 | Triazolones as apolipoprotein-B synthesis inhibitors The present invention concerns novel compounds of formula (I). ##STR1## wherein R1 is C1-10 alkyl, C3-7 cycloalkyl or C1-6 alkyl substituted with C3-7 cycloalkyl; R2 is hydrogen or C | 07/13/1999 |
| 5863923 | Dimethylbenzofuran and dimethylbenzopyran derivatives and their use as 5-HT3 antagonists Method of treating 5-HT3 -mediated disorders, which comprises systemic administration of an effective amount of a compound of formula (I) ##STR1## the pharmaceutically acceptable acid addition salt forms and the stereochemically isomeric f... | 01/26/1999 |
| 5854260 | Enterokinetic benzamide The present invention is concerned with a novel benzamide derivative of formula (I). ##STR1## Pharmaceutical compositions comprising said novel compounds, processes for preparing compounds and compositions, and the use thereof as a medicine, in ... | 12/29/1998 |
